|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 44.38 USD | -2.33% |
|
+0.10% | +0.58% |
| 14/01 | Truist Securities Adjusts Price Target on Exelixis to $51 From $49, Maintains Buy Rating | MT |
| 13/01 | Exelixis, Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-12-2026 05:15 PM |
Official Publications
No official publication found
- Stock Market
- Equities
- EXEL Stock
- News Exelixis, Inc.
- Official Publications
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















